Literature DB >> 20729985

N-Alkyl-octahydroisoquinolin-1-one-8-carboxamides: a Novel Class of Selective, Nonbasic, Nitrogen-Containing κ-Opioid Receptor Ligands.

Kevin J Frankowski1, Partha Ghosh, Vincent Setola, Thuy B Tran, Bryan L Roth, Jeffrey Aubé.   

Abstract

Herein we report that N-alkyl-octahydroisoquinolin-1-one-8-carboxamides are a novel class of readily-synthesized, selective ϰ-opioid receptor (KOR) ligands. A striking feature of this class of compounds is the absence of any basic nitrogen atoms. Many of these compounds have demonstrated exclusive affinity for the KOR over not only the δ-opioid receptor (DOR) and the μ-opioid receptor (MOR), but 38 other GPCR targets as well. The general binding affinity of this class of compounds for the KOR combined with a streamlined route for analog synthesis provide strong motivation for pursuing this interesting new scaffold as a basis toward new probes targeting the KOR.

Entities:  

Year:  2010        PMID: 20729985      PMCID: PMC2923850          DOI: 10.1021/ml100040t

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  18 in total

1.  5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist.

Authors:  R M Jones; P S Portoghese
Journal:  Eur J Pharmacol       Date:  2000-05-12       Impact factor: 4.432

Review 2.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

Review 3.  Kappa opioid antagonists: past successes and future prospects.

Authors:  Matthew D Metcalf; Andrew Coop
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

4.  Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.

Authors:  M J Millan
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

5.  Benzeneacetamide amines: structurally novel non-m mu opioids.

Authors:  J Szmuszkovicz; P F Von Voigtlander
Journal:  J Med Chem       Date:  1982-10       Impact factor: 7.446

6.  Kappa opioid inhibition of morphine and cocaine self-administration in rats.

Authors:  S D Glick; I M Maisonneuve; J Raucci; S Archer
Journal:  Brain Res       Date:  1995-05-29       Impact factor: 3.252

7.  Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.

Authors:  Daniel Kracht; Elisabeth Rack; Dirk Schepmann; Roland Fröhlich; Bernhard Wünsch
Journal:  Org Biomol Chem       Date:  2009-11-12       Impact factor: 3.876

8.  Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).

Authors:  Juan Pablo Cueva; Tingwei Bill Cai; S Wayne Mascarella; James B Thomas; Hernán A Navarro; F Ivy Carroll
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

9.  Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.

Authors:  Allison T Knoll; Edward G Meloni; James B Thomas; F Ivy Carroll; William A Carlezon
Journal:  J Pharmacol Exp Ther       Date:  2007-09-06       Impact factor: 4.030

Review 10.  Peptide kappa opioid receptor ligands: potential for drug development.

Authors:  Jane V Aldrich; Jay P McLaughlin
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

View more
  13 in total

1.  Resolution of carboxylic acids using copper(I)-promoted removal of propargylic esters under neutral conditions.

Authors:  Partha Ghosh; Jeffrey Aubé
Journal:  J Org Chem       Date:  2011-04-14       Impact factor: 4.354

2.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions.

Authors:  Landon R Whitby; Yoshio Ando; Vincent Setola; Peter K Vogt; Bryan L Roth; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-06-15       Impact factor: 15.419

4.  Semisynthetic neoclerodanes as kappa opioid receptor probes.

Authors:  Kimberly M Lovell; Tamara Vasiljevik; Juan J Araya; Anthony Lozama; Katherine M Prevatt-Smith; Victor W Day; Christina M Dersch; Richard B Rothman; Eduardo R Butelman; Mary Jeanne Kreek; Thomas E Prisinzano
Journal:  Bioorg Med Chem       Date:  2012-03-01       Impact factor: 3.641

5.  Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.

Authors:  Laura M Bohn; Jeffrey Aubé
Journal:  ACS Med Chem Lett       Date:  2017-07-05       Impact factor: 4.345

6.  Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity.

Authors:  Michael L Martini; Caroline Ray; Xufen Yu; Jing Liu; Vladimir M Pogorelov; William C Wetsel; Xi-Ping Huang; John D McCorvy; Marc G Caron; Jian Jin
Journal:  ACS Chem Neurosci       Date:  2019-08-20       Impact factor: 4.418

7.  Development of functionally selective, small molecule agonists at kappa opioid receptors.

Authors:  Lei Zhou; Kimberly M Lovell; Kevin J Frankowski; Stephen R Slauson; Angela M Phillips; John M Streicher; Edward Stahl; Cullen L Schmid; Peter Hodder; Franck Madoux; Michael D Cameron; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

Review 8.  Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.

Authors:  Jolien De Neve; Thomas M A Barlow; Dirk Tourwé; Frédéric Bihel; Frédéric Simonin; Steven Ballet
Journal:  RSC Med Chem       Date:  2021-04-21

9.  A pharmacological organization of G protein-coupled receptors.

Authors:  Henry Lin; Maria F Sassano; Bryan L Roth; Brian K Shoichet
Journal:  Nat Methods       Date:  2013-01-06       Impact factor: 28.547

10.  Remodelling of the natural product fumagillol employing a reaction discovery approach.

Authors:  Bradley R Balthaser; Meghan C Maloney; Aaron B Beeler; John A Porco; John K Snyder
Journal:  Nat Chem       Date:  2011-12       Impact factor: 24.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.